vimarsana.com

Page 211 - பல்கலைக்கழகம் ஆஃப் மேற்கு ஆஸ்திரேலியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Curtin Alzheimer s research project awarded NHMRC funding

Date Time Curtin Alzheimer’s research project awarded NHMRC funding Curtin University has been awarded $637,536 in Federal Government funding to explore new treatment opportunities for patients who are at an increased risk of Alzheimer’s disease. Federal Minister for Health, the Hon Greg Hunt, today announced the project, which will be led by Professor John Mamo from the Curtin Health Innovation Research Institute (CHIRI) based at Curtin University, was successful in the National Health and Medical Research Council (NHMRC) 2020 Ideas grants. Curtin’s Deputy Vice-Chancellor Research Professor Chris Moran congratulated Professor Mamo and his team on their funding success. “This project is based on a remarkable discovery which suggests that in some individuals, Alzheimer’s disease may be caused by damaged microscopic blood vessels that directly supply the brain. These vessels have been damaged by a protein found in the blood that is produced in the liver,” Professor Mor

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC

Zelira Therapeutics Expands HOPE™ Distribution in the US Through Licensing Agreement with Alternative Solutions in Washington DC Agreement Signifies HOPE s Largest Expansion to Date, Major Milestone in Zelira s US Growth Strategy News provided by Share this article PHILADELPHIA, Dec. 15, 2020 /PRNewswire/  Zelira Therapeutics Ltd (ASX:ZLD,OTCQB:ZLDAF), a global leader in the development of clinically validated cannabis medicines, is pleased to announce it has entered into a binding licensing agreement with Alternative Solutions, a licensed grower, manufacturer and distributor of medical cannabis products in the District of Columbia (Washington DC). Under the agreement, Alternative Solutions will produce and distribute the HOPE™ line of products, Zelira s top-selling treatment developed for autism patients, throughout the legal DC medical cannabis market beginning in Q2 2021.

中国 战狼外交 再出击,澳大利亚为何成为针对目标 - BBC News 中文

中国 战狼外交 再出击,澳大利亚为何成为针对目标 - BBC News 中文
bbc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bbc.com Daily Mail and Mail on Sunday newspapers.

Frontiers | Barriers and Considerations for Diagnosing Rare Diseases in Indigenous Populations

2National Centre for Indigenous Genomics, Australian National University, Canberra, ACT, Australia 3Department of Pharmacology, Dalhousie University, Halifax, NS, Canada 4Precision Medicine, Platform on Shaping the Future of Health and Healthcare, World Economic Forum, San Francisco, CA, United States 5Institute of Genetics, Canadian Institutes of Health Research, Government of Canada, Ottawa, ON, Canada 6Human Metabolomics, North-West University, Potchefstroom, South Africa 7Facultad de Medicina, Center for Genetics and Genomics, Clinica Alemana Universidad del Desarrollo, Santiago, Chile 8Institute of Health Management, Southern Medical University, Guangdong, China 9KwaZulu-Natal Research Innovation and Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa 10Rare Diseases South Africa, Johannesburg, South Africa

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.